PL2444811T3 - Sposoby diagnozowania lub prognozowania raka jelita grubego - Google Patents

Sposoby diagnozowania lub prognozowania raka jelita grubego

Info

Publication number
PL2444811T3
PL2444811T3 PL10730815T PL10730815T PL2444811T3 PL 2444811 T3 PL2444811 T3 PL 2444811T3 PL 10730815 T PL10730815 T PL 10730815T PL 10730815 T PL10730815 T PL 10730815T PL 2444811 T3 PL2444811 T3 PL 2444811T3
Authority
PL
Poland
Prior art keywords
prognosis
diagnosis
methods
colorectal cancer
colorectal
Prior art date
Application number
PL10730815T
Other languages
English (en)
Inventor
Álvarez José Ignacio Casal
Manchado Rodrigo Barderas
Ingrid Henriette Suzanne Babel
Original Assignee
Consejo Superior Investigacion
Fundacion Centro Nac De Investigaciones Oncologicas Carlos Iii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion, Fundacion Centro Nac De Investigaciones Oncologicas Carlos Iii filed Critical Consejo Superior Investigacion
Publication of PL2444811T3 publication Critical patent/PL2444811T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82Translation products from oncogenes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
PL10730815T 2009-05-25 2010-05-25 Sposoby diagnozowania lub prognozowania raka jelita grubego PL2444811T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200930203A ES2361808B8 (es) 2009-05-25 2009-05-25 Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal.
EP10730815.7A EP2444811B1 (en) 2009-05-25 2010-05-25 Methods for the diagnosis or prognosis of colorectal cancer
PCT/ES2010/070350 WO2010136629A1 (es) 2009-05-25 2010-05-25 Métodos para el diagnóstico o pronóstico del cáncer colorrectal

Publications (1)

Publication Number Publication Date
PL2444811T3 true PL2444811T3 (pl) 2016-01-29

Family

ID=42542763

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10730815T PL2444811T3 (pl) 2009-05-25 2010-05-25 Sposoby diagnozowania lub prognozowania raka jelita grubego

Country Status (7)

Country Link
US (1) US20120101003A1 (pl)
EP (1) EP2444811B1 (pl)
AU (1) AU2010252907B2 (pl)
CA (1) CA2763557C (pl)
ES (2) ES2361808B8 (pl)
PL (1) PL2444811T3 (pl)
WO (1) WO2010136629A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9766253B2 (en) 2012-07-30 2017-09-19 Institut National De La Sante Et De La Recherche Medicale (Inserm) Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
US20160333418A1 (en) * 2014-01-14 2016-11-17 Santa Maria Biotherapeutics, Inc. Activin Inhibitor Response Prediction and Uses for Treatment
CN104777310A (zh) * 2015-01-23 2015-07-15 郑振海 一种肿瘤相关抗体定量检测试剂盒
ES2619116B1 (es) * 2015-12-23 2018-04-12 Fundación Para La Investigación Biomédica Del Hospital Universitario 12 De Octubre Biomarcador para el diagnóstico, pronóstico y seguimiento de cáncer colorrectal de aparición precoz
CN110456069A (zh) * 2019-07-31 2019-11-15 四川大学华西医院 Zap70自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
CN110488014A (zh) * 2019-08-27 2019-11-22 成都和同易创生物科技有限公司 一种检测结直肠癌转移潜能的试剂盒及其使用方法
CN116670510A (zh) * 2020-10-05 2023-08-29 福瑞诺姆控股公司 用于结肠细胞增殖性病症的早期检测的标志物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275851A1 (en) * 2000-07-26 2006-12-07 Emmert-Buck Michael R Layered peptide/antigen arrays - for high-throughput antibody screening of clinical samples
US20030148314A1 (en) * 2001-08-01 2003-08-07 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer
EP1824995A2 (en) * 2004-11-24 2007-08-29 St. George's Enterprises Limited Diagnosis of prostate cancer
AU2006259583A1 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
US20080254481A1 (en) * 2006-11-13 2008-10-16 Invitrogen Corporation Methods and kits for detecting prostate cancer biomarkers
MX2011000655A (es) * 2008-07-18 2011-03-21 Oragenics Inc Composiciones para la deteccion y tratamiento de cancer colorrectal.

Also Published As

Publication number Publication date
EP2444811A1 (en) 2012-04-25
EP2444811B1 (en) 2015-08-05
ES2361808B8 (es) 2012-11-29
CA2763557C (en) 2019-04-23
WO2010136629A1 (es) 2010-12-02
ES2361808A1 (es) 2011-06-22
ES2361808B1 (es) 2012-05-16
CA2763557A1 (en) 2010-12-02
ES2551713T3 (es) 2015-11-23
US20120101003A1 (en) 2012-04-26
AU2010252907B2 (en) 2016-03-17
AU2010252907A1 (en) 2012-01-12
WO2010136629A9 (es) 2011-01-20

Similar Documents

Publication Publication Date Title
WO2011008262A9 (en) Methods and apparatus for diagnosis and/or prognosis of cancer
ZA201300519B (en) Novel antibody for the diagnosis and/or prognosis of cancer
AP2011005956A0 (en) Methods of treatment for solid tumors.
ZA201203010B (en) Diagnostic methods for determining prognosis of non-small cell lung cancer
GB0906458D0 (en) Macromolecules for diagnosis and prognosis
PL2482849T3 (pl) Skojarzona immunoterapia w leczeniu nowotworu
EP2542585B8 (en) Methods for treating colorectal cancer
EP2401406A4 (en) METHODS OF DETECTING LUNG CANCER
EP2438197A4 (en) METHOD OF CANCER DETECTION
WO2011163332A9 (en) Methods for detecting cancer
PT3106875T (pt) Método para a deteção de cancro
EP2428584A4 (en) COLORECTAL TUMOR DETECTION METHOD
IL213761A0 (en) Novel ortho-aminoamides for the treatment of cancer
GB201012590D0 (en) Methods for diagnosing cancer
GB0820309D0 (en) Detection of cancer
PL2444811T3 (pl) Sposoby diagnozowania lub prognozowania raka jelita grubego
GB201011171D0 (en) Method for diagnosing lung cancer
SG11201402115TA (en) Methods for diagnosis and/or prognosis of gynecological cancer
ZA201202170B (en) Detecting pax2 for the diagnosis of breast cancer
ZA201203011B (en) Diagnostic methods for determining prognosis of non-small cell lung cancer
PL388252A1 (pl) Terapia skojarzona raka jelita grubego
EP2363499A4 (en) DIAGNOSTIC PROCEDURE FOR COLORECTAL CARCINOMA
AP2011005893A0 (en) Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer.
GB0822345D0 (en) Methods and compositions for cancer prognosis
GB201508380D0 (en) Methods for diagnosis, prognosis, and of determining the treatment for acute leukaemia